FLUOROURACIL - BIOCHEMISTRY AND PHARMACOLOGY

被引:784
作者
PINEDO, HM [1 ]
PETERS, GFJ [1 ]
机构
[1] FREE UNIV HOSP AMSTERDAM,DEPT ONCOL,POB 7057,1007 MB AMSTERDAM,NETHERLANDS
关键词
D O I
10.1200/JCO.1988.6.10.1653
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1653 / 1664
页数:12
相关论文
共 61 条
  • [1] BAPAT AR, 1983, J BIOL CHEM, V258, P4130
  • [2] BERGER SH, 1984, MOL PHARMACOL, V25, P303
  • [3] CONTINUOUS 5-DAY REGIONAL CHEMOTHERAPY BY 5-FLUOROURACIL IN COLON-CARCINOMA - PHARMACOKINETIC EVALUATION
    BOUBLIL, JL
    MILANO, G
    KHATER, R
    BOURRY, J
    THYSS, A
    BRUNETON, JN
    RENEE, N
    PHILIP, C
    NAMER, M
    [J]. BRITISH JOURNAL OF CANCER, 1985, 52 (01) : 15 - 20
  • [4] BROCKMAN RW, 1977, CANCER, V40, P2681, DOI 10.1002/1097-0142(197711)40:5+<2681::AID-CNCR2820400941>3.0.CO
  • [5] 2-E
  • [6] CHABNER BA, 1982, PHARM PRINCIPLES CAN, P183
  • [8] NON-LINEAR PHARMACOKINETIC MODELS FOR 5-FLUOROURACIL IN MAN - INTRAVENOUS AND INTRAPERITONEAL ROUTES
    COLLINS, JM
    DEDRICK, RL
    KING, FG
    SPEYER, JL
    MYERS, CE
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) : 235 - 246
  • [9] THYMIDYLATE SYNTHETASE - TARGET ENZYME IN CANCER CHEMOTHERAPY
    DANENBERG, PV
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1977, 473 (02) : 73 - 92
  • [10] DANENBERG PV, 1982, MOL CELL BIOCHEM, V43, P49